Mass Cytometry in Vaccine Development | Patrick Reeves, PhD

In this webinar, Patrick Reeves discusses utility and considerations.
(*This webinar first aired on July 7, 2020, at the Fluidigm Infectious Disease and Oncology Virtual Summit.)

ABOUT THE WEBINAR:
In this presentation Patrick Reeves of Harvard Medical School and Massachusetts General Hospital discusses how mass cytometry can benefit vaccine research programs to:

- Overcome hurdles during development
- Deliver valuable insights into efficacy and immune response
- Inform the evaluation of candidate vaccines

Results and lessons from the development of a novel vaccine for Coxiella burnetii and other examples illustrate key benefits, challenges and considerations for integrating mass cytometry into vaccine research programs.

ABOUT THE PRESENTER:
Patrick Reeves, PhD
Instructor in Medicine, Harvard Medical School
Team Leader, Vaccine and Immunotherapy Center,
Massachusetts General Hospital

REFERENCE:
https://www.nature.com/articles/s41598-020-69327-x.pdf

Embed